A share price of Geron Corp [GERN] is currently trading at $4.07, up 1.24%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GERN shares have gain 11.20% over the last week, with a monthly amount glided 1.75%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Geron Corp [NASDAQ: GERN] stock has seen the most recent analyst activity on November 05, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $8. On September 09, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $7 on the stock. Robert W. Baird downgraded its rating to a Neutral but stick to its price target of $4.50 on April 30, 2024. TD Cowen initiated its recommendation with a Buy and recommended $10 as its price target on April 29, 2024. Needham reiterated a Buy rating for this stock on March 15, 2024, and upped its price target to $5. In a note dated September 12, 2023, Goldman upgraded an Buy rating on this stock but restated the target price of $4.
Geron Corp experienced fluctuations in its stock price throughout the past year between $1.64 and $5.34. Currently, Wall Street analysts expect the stock to reach $6.13 within the next 12 months. Geron Corp [NASDAQ: GERN] shares were valued at $4.07 at the most recent close of the market. An investor can expect a potential return of 50.61% based on the average GERN price forecast.
Analyzing the GERN fundamentals
Trailing Twelve Months sales for Geron Corp [NASDAQ:GERN] were 29.48M which represents 17138.41% growth. Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at -7.07%, Pretax Profit Margin comes in at -6.84%, and Net Profit Margin reading is -6.84%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.68 and Total Capital is -0.79. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.99 points at the first support level, and at 3.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.13, and for the 2nd resistance point, it is at 4.19.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Geron Corp [NASDAQ:GERN] is 2.89. Further, the Quick Ratio stands at 2.74, while the Cash Ratio is 0.44. Considering the valuation of this stock, the price to sales ratio is 84.50, the price to book ratio is 8.40.
Transactions by insiders
Recent insider trading involved GRETHLEIN ANDREW J, EVP, Chief Operating Officer, that happened on Jul 08 ’24 when 0.67 million shares were sold. EVP, Chief Medical Officer, Feller Faye completed a deal on Jun 10 ’24 to sell 0.29 million shares. Meanwhile, EVP, Corp Strategy & CCO Kapur Anil sold 0.42 million shares on Jun 10 ’24.
